mrdcll | 19615

Minimal residual disease CLL

Keywords

CLL therapy, MRD CLL, Remission, Residual disease

Material
Blood EDTA
EDTA tube, purple (6)
Min. quantity 2 mL
Stability 2 days / 18-25°C; 2 days / 2-8°C
Duration 1 day
Frequency 6 x per week (monday - saturday)
Method Immunophenotyping
Price CHF 129.60
Tariff 129.60 TP
Designation see single analyses

Single analyses

MRD 4 (1 CLL/10'000 Lc)
emrd4
emrd4
MRD 3 (1 CLL/1'000 Lc)
emrd3
emrd3
MRD cell events
emrd
emrd
B cells events
ebly
ebly
Leukocyte events, Lc
elc
elc

Team of consultants

PhD Christian Kalberer FAMH Specialist in laboratory medicine, main field hematology
FAMH Specialist in laboratory medicine, main field hematology T +41 61 486 15 14
PD, MD Giuseppe Colucci FMH internal medicine, hematology, FAMH Specialist in laboratory medicine
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine T +41 61 486 14 57
MD FMH hematology, FAMH Specialist in laboratory medicine Maurice Redondo Head of Production
Head of Production T +41 61 486 11 11